Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Clinical and Laboratory Efficacy of Autogemotherapy Based on Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer

NCT03113019 is registered in ClinicalTrials.gov with Research Institute of Fundamental and Clinical Immunology as lead sponsor.

NCT NCT03113019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03113019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Clinical and Laboratory Efficacy of Autogemotherapy Based on Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer
Lead sponsor
Research Institute of Fundamental and Clinical Immunology
Phase
Phase 1
Overall status
Unknown status
Start date
February 11, 2014
Completion date
September 11, 2017
Enrollment
26 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer